Core Viewpoint - The company has released its 2025 semi-annual report, which includes details on financial performance, management decisions, and future plans, emphasizing the importance of transparency and compliance with regulatory requirements [5][8][70]. Company Overview - Company Name: Zhongzhu Medical Holdings Co., Ltd. [5] - Stock Code: 600568 [5] - The report is unaudited and aims to provide a comprehensive view of the company's operational results and financial status [2][8]. Financial Data - The report includes key financial data, although specific figures are not detailed in the provided text [4]. - There was no profit distribution or capital reserve transfer during the reporting period [3]. Important Matters - The company has not reported any significant changes in its operational situation during the reporting period [4]. - The board of directors and supervisory board have confirmed the authenticity and completeness of the report [1][5]. Board Meeting Decisions - The board meeting on August 27, 2025, approved the semi-annual report and its summary with unanimous consent [8][69]. - The board also approved a special report on the use of raised funds, which will be disclosed in detail [11][71]. - A proposal to change the accounting firm to Beijing Dehao International Accounting Firm was approved, with audit fees set at 800,000 RMB for financial audit and 300,000 RMB for internal control audit [12][76]. Fund Management - The report outlines the management and usage of raised funds, ensuring compliance with relevant regulations [16][18]. - As of June 30, 2025, the company has utilized 650 million RMB for working capital and various acquisition projects [23]. Upcoming Shareholder Meeting - The company will hold its first extraordinary general meeting of 2025 on September 15, 2025, to discuss the approved proposals [15][41].

Group 1 - Company ST Zhongzhu announced that its 10th Board of Directors held its 9th meeting on August 27, 2025, combining in-person and telecommunication methods [1] - The meeting reviewed the proposal for convening the company's first extraordinary general meeting of shareholders in 2025 [1]

Group 1 - The board of directors of Zhongzhu Medical Holdings Co., Ltd. held its ninth meeting and approved the 2025 semi-annual report and summary with unanimous support [1][2] - The board also approved a special report on the use of raised funds for the first half of 2025, which complies with relevant regulations [2] - A proposal to change the accounting firm was approved, with Beijing Dehao International Accounting Firm being selected for the 2025 financial and internal control audits, with fees set at 800,000 yuan for financial audit and 300,000 yuan for internal control audit [2][3] Group 2 - The board approved the convening of the first extraordinary general meeting of 2025, scheduled for September 15, 2025, at the company's headquarters [3]

Group 1 - The Supervisory Board of Zhongzhu Medical Holdings Co., Ltd. held its fourth meeting and approved the 2025 semi-annual report and summary with unanimous support [1][2] - The meeting also approved a special report on the use of raised funds for the first half of 2025, with all votes in favor [2] - A resolution to change the accounting firm was passed, with the Supervisory Board confirming that the decision followed legal and regulatory requirements and did not harm the interests of shareholders, especially minority shareholders [3] Group 2 - The new accounting firm, Beijing Dehao International Accounting Firm, has qualifications for securities and futures-related business and has extensive auditing experience [3] - The decision to change the accounting firm will be submitted to the company's first extraordinary general meeting of shareholders in 2025 for approval [3]

Meeting Information - The first extraordinary general meeting of shareholders for 2025 will be held on September 15, 2025 [1] - The meeting will utilize a combination of on-site and online voting methods [1][2] - The on-site meeting will take place at 10:00 AM at Renheng Binhai Center, Zhuhai [1] Voting Procedures - Online voting will be conducted through the Shanghai Stock Exchange's system, available from 9:15 AM to 3:00 PM on the day of the meeting [2][4] - Shareholders with multiple accounts can aggregate their voting rights across all accounts [5] - Duplicate voting through different methods will be counted based on the first vote cast [5] Attendance and Registration - Shareholders registered by the close of business on September 8, 2025, are eligible to attend [6] - Registration for attendance requires specific documentation, including identification and stock account information [6] Other Considerations - The company will notify attendees of any significant events that may affect the meeting's proceedings [6] - An authorization letter template is provided for shareholders wishing to delegate their voting rights [7][8]

Meeting Agenda - The first extraordinary general meeting of shareholders for 2025 is scheduled for September 15, 2025, at 10:00 AM in Zhuhai [1] - The meeting will be chaired by Chairman Chen Xu [1] Meeting Regulations - The company emphasizes the importance of maintaining the legal rights of all shareholders and ensuring the orderly conduct of the meeting [2] - Only authorized personnel, including shareholders, directors, supervisors, and relevant staff, are allowed to enter the meeting venue [2] - Attendees must follow registration procedures and maintain order during the meeting [2][4] Voting Procedures - Shareholders must present identification and relevant documents to register for the meeting [3] - The meeting will include a report on the number of attending shareholders and their voting rights before proceeding with the agenda [3] - Voting will be conducted through a named ballot system, and invalid votes will be discarded [4][5] Proposal for Change of Auditor - The company proposes to change its accounting firm to Beijing Dehao International Accounting Firm for the 2025 fiscal year [5][10] - The decision follows a public tender process, with Dehao International selected based on its qualifications and experience [6][10] - The previous auditor, Dahua Accounting Firm, provided services for five years and issued a qualified opinion in 2024 [9][10] Auditor's Qualifications - Dehao International was established in December 2008 and has 66 partners and 300 registered accountants [7] - The firm has experience in auditing various industries, including manufacturing and information services [7] - The proposed signing partners have significant experience in auditing listed companies [8] Financial Implications - The audit fee for 2025 is proposed to be 800,000 yuan, with an additional 300,000 yuan for internal control audits [9] - The company seeks authorization from the shareholders' meeting to adjust the audit fees based on changes in the audit scope [9][10] Board Approval - The board of directors unanimously approved the proposal to appoint Dehao International as the new auditor [11] - All nine directors present voted in favor, with no opposition or abstentions [11]

证券代码：600568 证券简称：ST 中珠 公告编号：2025-038 号 中珠医疗控股股份有限公司 2025 年半年度募集资金存放与使用情况的专项报告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《上市公司募集资金监管规则》和《上海证券交易所上市公司自律监管指引 第 1 号——规范运作（2025 年 5 月修订）》的规定，中珠医疗控股股份有限公司（以 下简称"公司"、"本公司"）将 2025 年半年度募集资金存放与实际使用情况专项说 明如下： 一、募集资金基本情况 重大资产重组募集配套资金基本情况 根据本公司 2015 年 9 月第七届董事会第四十一次会议和 2015 年 10 月第一次临时 股东大会会议，并经中国证券监督管理委员会《关于核准中珠控股股份有限公司向深 圳市一体投资控股集团有限公司等发行股份购买资产并募集配套资金的批复》（证监 许可[2016]226 号）文件核准，本公司向深圳市一体投资控股集团有限公司发行 96,071,607 股股份、向深圳市一体正润资产管理有限公司发行 28,02 ...

证券代码：600568 证券简称：ST 中珠 公告编号：2025-037 号 中珠医疗控股股份有限公司 第十届监事会第四次会议决议公告 特别提示 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 1、中珠医疗控股股份有限公司（以下简称"中珠医疗"或"公司"）第十届 监事会第四次会议的召开符合有关法律、行政法规、部门规章、规范性文件和《公 司章程》的规定。 2、本次监事会会议于 2025 年 8 月 15 日以电话、邮件、微信送达方式发出 通知。 3、本次监事会会议于 2025 年 8 月 27 日以现场结合通讯会议的方式召开。 4、本次监事会会议应出席监事 3 人，实际出席监事 3 人。 二、监事会会议审议情况 （一）审议通过《公司 2025 年半年度报告全文》及摘要； 表决结果为：同意 3 票，反对 0 票，弃权 0 票。 根据《证券法》第 82 条的规定和《公开发行证券的公司信息披露内容与格 式准则第 3 号——半年度报告的内容与格式（2025 年修订）》等有关要求，我们 作为公司监事在全面了解和审核 ...

中珠医疗控股股份有限公司 第十届董事会审计委员会第七次会议（现场）决议 中珠医疗控股股份有限公司〈以下简称"中珠医疗"或"公司"第十届董 事会审计委员会第七次会议于 2025年 8 月 15 日以电话、邮件、微信等送达方式 通知各位委员,于 2025年 8 月 27 日以现场表决的方式召开,会议应参与委员 5 人,实际参与委员 5 人,根据《公司法》《公司章程》及《中珠医疗控股股份有 限公司董事会审计委员会工作细则》等有关规定,对公司提交的相关议案进行了 审议,通过以下议案: (一) 审议通过《公司 2025 年半年度报告全文》及摘要; 表决结果:同意5票,反对0票,弃权0票。 董事会审计委员会同意将《公司 2025 年半年度报告全文》及摘要提交公司 第十届董事会第八次会议审议。 (二) 审议通过《关于变更会计师事务所的议案》。 表决结果:同意5票,反对0票,弃权 0 票。 董事会审计委员会同意将《关于变更会计师事务所的议案》提交公司第十届 董事会第八次会议审议。 中珠医疗控股股份有限 (以下无正文,为中珠医疗控股股份有限公司第十届董事会审计委员会第七次会 议决议签字页 ) 全体委员: 张 電 陈 旭 武 有 ...

证券代码：600568 证券简称：ST 中珠 公告编号：2025-036 号 中珠医疗控股股份有限公司 第十届董事会第九次会议决议公告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 1、中珠医疗控股股份有限公司（以下简称"中珠医疗"或"公司"）第十 届董事会第九次会议的召开符合有关法律、行政法规、部门规章、规范性文件 和《公司章程》的规定。 2、本次董事会会议于 2025 年 8 月 15 日以电话、邮件、微信送达方式发出 通知。 3、本次董事会会议于 2025 年 8 月 27 日以现场结合通讯会议的方式召开。 4、本次董事会会议应出席董事 9 人，实际出席董事 9 人。公司全体监事和 高管列席了本次会议。 根据中国证监会《公开发行证券的公司信息披露内容与格式准则第 3 号— —半年度报告的内容与格式（2025 年修订）》《上海证券交易所股票上市规则 （2025 年 4 月修订）》等有关规定，结合公司及下属子公司 2025 年半年度的整 体经营及年度审计情况，公司编制了《2025 年半年度 ...